Contact
searchSearch
HMP Global

Rheumatology & Arthritis

Featured

Shikha Singla
Expert Insights
Shikha Singla, MD, on Comparative Analysis of Guidelines for PsA
05/10/2026
Shikha Singla, MD
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the...
05/10/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA: Part 2
04/30/2026
Philip Mease, MD
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of...
04/30/2026
Rheumatology & Arthritis
Robert Terkeltaub
Expert Insights
Robert Terkeltaub, MD, on the Impact of the Gut Microbiome in Gout
04/23/2026
Robert Terkeltaub, MD
In part 1 of this video, Dr Robert Terkeltaub reviews how certain mechanisms by which the gut microbiome and genetic variants can affect the disease course of gout.
In part 1 of this video, Dr Robert Terkeltaub reviews how certain mechanisms by which the gut microbiome and genetic variants can affect the disease course of gout.
In part 1 of this video, Dr...
04/23/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA
04/23/2026
Philip Mease, MD
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast,...
04/23/2026
Rheumatology & Arthritis
Alexis Ogdie
Expert Insights
Alexis Ogdie, MD, on the Impact of Obesity in Psoriatic Arthritis: Part 1
04/15/2026
Alexis Ogdie, MD
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In the first of two videos on...
04/15/2026
Rheumatology & Arthritis
Alexis Ogdie
Expert Insights
Alexis Ogdie, MD, on Obesity in Psoriatic Arthritis and GLP-1s: Part 2
04/15/2026
Alexis Ogdie, MD
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
In part 2 of her video on...
04/15/2026
Rheumatology & Arthritis
Clinical Trials
Shorter Pegloticase Infusions Maintain Safety and Efficacy in Uncontrolled Gout
03/18/2026
Jessica Garlewicz
For practicing rheumatologists, the key takeaway is that a 60-minute infusion may offer a more practical option without compromising outcomes.
For practicing rheumatologists, the key takeaway is that a 60-minute infusion may offer a more practical option without compromising outcomes.
For practicing rheumatologists,...
03/18/2026
Rheumatology & Arthritis
Research Highlights
Nearly Half of Patients With Gout Have Metabolic Syndrome
03/18/2026
Jessica Garlewicz
Recent analysis underscores the need for broader cardiometabolic assessment in gout management and reinforce gout as a multisystem disease.
Recent analysis underscores the need for broader cardiometabolic assessment in gout management and reinforce gout as a multisystem disease.
Recent analysis underscores the...
03/18/2026
Rheumatology & Arthritis
Research Summary
Fibromyalgia Creates High Global Burden of Depression and Anxiety
02/17/2026
Jessica Garlewicz
This first large-scale meta-analysis quantifies the substantial global prevalence of depression and anxiety in fibromyalgia patients, highlighting the need for integrated screening and holistic management approaches in clinical practice.
This first large-scale meta-analysis quantifies the substantial global prevalence of depression and anxiety in fibromyalgia patients, highlighting the need for integrated screening and holistic management approaches in clinical practice.
This first large-scale...
02/17/2026
Rheumatology & Arthritis
Clinical Trials
Bedtime Sublingual Cyclobenzaprine Improves Fibromyalgia Pain and Sleep
02/17/2026
Jessica Garlewicz
In fibromyalgia, nonrestorative sleep is closely linked to symptom severity.
In fibromyalgia, nonrestorative sleep is closely linked to symptom severity.
In fibromyalgia, nonrestorative...
02/17/2026
Rheumatology & Arthritis
Research Highlights
Achieving Serum Urate Target Linked to Lower Cardiovascular Risk in Gout
02/17/2026
Jessica Garlewicz
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout who achieved...
02/17/2026
Rheumatology & Arthritis

Videos

Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA: Part 2
05/01/2026
Philip Mease, MD
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of...
05/01/2026
Rheumatology & Arthritis
Robert Terkeltaub
Expert Insights
Robert Terkeltaub, MD, on the Impact of the Gut Microbiome in Gout
04/23/2026
Robert Terkeltaub, MD
In part 1 of this video, Dr Robert Terkeltaub reviews how certain mechanisms by which the gut microbiome and genetic variants can affect the disease course of gout.
In part 1 of this video, Dr Robert Terkeltaub reviews how certain mechanisms by which the gut microbiome and genetic variants can affect the disease course of gout.
In part 1 of this video, Dr...
04/23/2026
Rheumatology & Arthritis
Alexis Ogdie
Expert Insights
Alexis Ogdie, MD, on Obesity in Psoriatic Arthritis and GLP-1s: Part 2
04/16/2026
Alexis Ogdie, MD
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
In part 2 of her video on...
04/16/2026
Rheumatology & Arthritis
Alexis Ogdie
Expert Insights
Alexis Ogdie, MD, on the Impact of Obesity in Psoriatic Arthritis: Part 1
04/16/2026
Alexis Ogdie, MD
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In the first of two videos on...
04/16/2026
Rheumatology & Arthritis
Laura Coates
Expert Insights
Laura Coates, MBChB, on Progression to Psoriatic Arthritis from Psoriasis
04/16/2026
Laura Coates, MBChB
Dr Coates discusses a post-hoc analysis of the FOREMOST study that aimed to identify psoriatic arthritis patients at the highest risk of progressing from fewer than 5 tender or swollen joints to polyarticular disease with much higher counts...
Dr Coates discusses a post-hoc analysis of the FOREMOST study that aimed to identify psoriatic arthritis patients at the highest risk of progressing from fewer than 5 tender or swollen joints to polyarticular disease with much higher counts...
Dr Coates discusses a post-hoc...
04/16/2026
Rheumatology & Arthritis
Alexis Ogdie
Expert Insights
Alexis Ogdie, MD, on the Impact of Obesity in Psoriatic Arthritis: Part 1
04/15/2026
Alexis Ogdie, MD
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In the first of two videos on...
04/15/2026
Rheumatology & Arthritis
Alexis Ogdie
Expert Insights
Alexis Ogdie, MD, on Obesity in Psoriatic Arthritis and GLP-1s: Part 2
04/15/2026
Alexis Ogdie, MD
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
In part 2 of her video on...
04/15/2026
Rheumatology & Arthritis
Videos
Identification and Diagnosis of Interstitial Lung Diseases (ILDs)
01/07/2026
Dinesh Khanna, MD, MSc
Discover how rheumatologist Dinesh Khanna, MD, MSc, approaches early recognition and accurate diagnosis of ILDs. The chapters in this video outline hallmark symptoms and risk factors, the initial workup, and when to refer patients for further...
Discover how rheumatologist Dinesh Khanna, MD, MSc, approaches early recognition and accurate diagnosis of ILDs. The chapters in this video outline hallmark symptoms and risk factors, the initial workup, and when to refer patients for further...
Discover how rheumatologist...
01/07/2026
Rheumatology & Arthritis
Alexis Ogdie
Conference Coverage
Alexis Ogdie, MD, on New and Emerging Therapies for Psoriatic Arthritis
11/25/2025
Alexis Ogdie, MD
Dr Ogdie provides updates on new and emerging therapies for psoriatic arthritis, which she presented at the ACR Convergence in Chicago.
Dr Ogdie provides updates on new and emerging therapies for psoriatic arthritis, which she presented at the ACR Convergence in Chicago.
Dr Ogdie provides updates on new...
11/25/2025
Rheumatology & Arthritis
Mark Hwang
Video
Mark Hwang, MD, on Inflammatory Back Pain
11/19/2025
Mark Hwang, MD
Dr Hwang reviews key findings of research he presented at ACR Convergence on inflammatory back pain and the importance of multimodality evaluation to identify patients with axial spondyloarthritis vs mechanical back pain.
Dr Hwang reviews key findings of research he presented at ACR Convergence on inflammatory back pain and the importance of multimodality evaluation to identify patients with axial spondyloarthritis vs mechanical back pain.
Dr Hwang reviews key findings of...
11/19/2025
Rheumatology & Arthritis

News

Research Highlights
Fibromyalgia Overlap in Psoriatic Arthritis Complicates Disease Assessment
05/14/2026
Rebecca Mashaw
Improved recognition and targeted assessment are essential to avoid misclassification of disease activity for patients with psoriatic arthritis and fibromyalgia.
Improved recognition and targeted assessment are essential to avoid misclassification of disease activity for patients with psoriatic arthritis and fibromyalgia.
Improved recognition and...
05/14/2026
Rheumatology & Arthritis
Clinical Trials
Shorter Pegloticase Infusions Maintain Safety and Efficacy in Uncontrolled Gout
03/18/2026
Jessica Garlewicz
For practicing rheumatologists, the key takeaway is that a 60-minute infusion may offer a more practical option without compromising outcomes.
For practicing rheumatologists, the key takeaway is that a 60-minute infusion may offer a more practical option without compromising outcomes.
For practicing rheumatologists,...
03/18/2026
Rheumatology & Arthritis
Research Summary
Target Serum Urate and CKD Progression in Gout
02/02/2026
Rebecca Mashaw
Achieving target serum urate levels with urate-lowering therapy is not linked to heightened risk of severe or end-stage kidney disease, according to a multinational cohort study,
Achieving target serum urate levels with urate-lowering therapy is not linked to heightened risk of severe or end-stage kidney disease, according to a multinational cohort study,
Achieving target serum urate...
02/02/2026
Rheumatology & Arthritis
News
Medicare Will Cover GLP-1s for Obesity Under Deal with Pharma
11/06/2025
Rebecca Mashaw
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said...
11/06/2025
Rheumatology & Arthritis
Conference Coverage
GWAS Identifies Novel Genetic Variants Associated With RA-ILD
10/27/2025
Jessica Garlewicz
Investigators reported at ACR Convergence 2025 that a genome risk score including 5 novel single nucleotide polymorphisms provides significant improvement in discriminating interstitial lung disease among patients with rheumatoid arthritis.
Investigators reported at ACR Convergence 2025 that a genome risk score including 5 novel single nucleotide polymorphisms provides significant improvement in discriminating interstitial lung disease among patients with rheumatoid arthritis.
Investigators reported at ACR...
10/27/2025
Rheumatology & Arthritis
Research Highlights
Treat-to-Target TNFi Tapering Maintains Effectiveness at 24 Months Among Patients With PsA, axSpA
09/09/2025
Rebecca Mashaw
Structured monitoring and patient-physician collaboration are critical to successful tapering of anti-tumor necrosis factor therapy for patients with psoriatic arthritis or axial spondyloarthritis.
Structured monitoring and patient-physician collaboration are critical to successful tapering of anti-tumor necrosis factor therapy for patients with psoriatic arthritis or axial spondyloarthritis.
Structured monitoring and...
09/09/2025
Rheumatology & Arthritis
News
Time Trends and Predictors of Gout Remission
09/04/2025
Rebecca Mashaw
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily...
09/04/2025
Rheumatology & Arthritis
Research Highlights
Adipokines Predict Incident Osteoporotic Fracture in Rheumatoid Arthritis
08/21/2025
Rebecca Mashaw
Elevated adiponectin and leptin independently and synergistically increase fracture risk in patients with rheumatoid arthritis.
Elevated adiponectin and leptin independently and synergistically increase fracture risk in patients with rheumatoid arthritis.
Elevated adiponectin and leptin...
08/21/2025
Rheumatology & Arthritis
News
Ageism Among Rheumatologists May Affect Care Delivery
08/21/2025
Rebecca Mashaw
Findings of recent study underscore the need for age-aware training and the adoption of frameworks like the Geriatric 5Ms to mitigate age-related disparities in rheumatologic care.
Findings of recent study underscore the need for age-aware training and the adoption of frameworks like the Geriatric 5Ms to mitigate age-related disparities in rheumatologic care.
Findings of recent study...
08/21/2025
Rheumatology & Arthritis
News
Male Patients with Axial Spondyloarthritis More Likely to Respond to Advanced Therapies, Meta-analysis Finds
08/11/2025
Jessica Garlewicz
Female patients were significantly older and had higher pain scores, while men had higher CRP levels, suggesting potential disparities in disease presentation and inflammation markers.
Female patients were significantly older and had higher pain scores, while men had higher CRP levels, suggesting potential disparities in disease presentation and inflammation markers.
Female patients were...
08/11/2025
Rheumatology & Arthritis

Podcasts

Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA
05/11/2026
Philip Mease, MD
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast,...
05/11/2026
Rheumatology & Arthritis
Shikha Singla
Expert Insights
Shikha Singla, MD, on Comparative Analysis of Guidelines for PsA
05/11/2026
Shikha Singla, MD
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the...
05/11/2026
Rheumatology & Arthritis
Shikha Singla
Expert Insights
Shikha Singla, MD, on Comparative Analysis of Guidelines for PsA
05/10/2026
Shikha Singla, MD
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the...
05/10/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA: Part 2
04/30/2026
Philip Mease, MD
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of...
04/30/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA
04/23/2026
Philip Mease, MD
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast,...
04/23/2026
Rheumatology & Arthritis
Expert Insights
Daniel Solomon, MD, on Treat to Target vs Symptoms in Gout
02/04/2026
Daniel Hal Solomon, MD
In this podcast, Dr Solomon reviews the design of, recruitment for, and established outcomes of the TRUST trial, a randomized controlled active comparator strategy for gout to compare a treat to target serum urate strategy versus an approach...
In this podcast, Dr Solomon reviews the design of, recruitment for, and established outcomes of the TRUST trial, a randomized controlled active comparator strategy for gout to compare a treat to target serum urate strategy versus an approach...
In this podcast, Dr Solomon...
02/04/2026
Rheumatology & Arthritis
Dacre Knight
Podcast
Dacre Knight, MD, on Hypermobility
04/30/2025
Dacre Knight, MD
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo...
04/30/2025
Rheumatology & Arthritis
Len Calabrese
Podcast
Leonard Calabrese, DO, on Long COVID Similarities to Fibromyalgia, ME/CFS
01/02/2025
Leonard Calabrese, DO
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Calabrese discusses the...
01/02/2025
Rheumatology & Arthritis
Misti Paudel
Podcast
Misti Paudel, PhD, on Difficult-to-Treat Rheumatoid Arthritis
08/12/2024
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she...
08/12/2024
Rheumatology & Arthritis
Vikas Majithia
Podcast
Vikas Majithia, MD, and Ronald Butendieck, MD, on the Continuing Challenges of Gout
06/20/2024
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck...
06/20/2024
Rheumatology & Arthritis

Conference Coverage

Conference Coverage
Smoking Modifies Link Between PTSD and Rheumatoid Arthritis Risk
10/31/2025
Riya Gandhi, MA
A large national study of U.S. veterans presented at ACR Convergence reveals that PTSD increases the risk of RA, especially in never-smokers, suggesting distinct immune mechanisms may drive disease in different exposure subgroups.
A large national study of U.S. veterans presented at ACR Convergence reveals that PTSD increases the risk of RA, especially in never-smokers, suggesting distinct immune mechanisms may drive disease in different exposure subgroups.
A large national study of U.S....
10/31/2025
Rheumatology & Arthritis
Conference Coverage
Anxiety, Depression, and Fibromyalgia Screening in RA Patients Reveals Symptom Burden Exceeding Seropositivity Rates
10/31/2025
Riya Gandhi, MA
Over 70% of rheumatoid arthritis patients who screen positive for anxiety, depression, or fibromyalgia report memory, sleep, or fatigue problems, highlighting the value of symptom checklists in noninflammatory disease assessment.
Over 70% of rheumatoid arthritis patients who screen positive for anxiety, depression, or fibromyalgia report memory, sleep, or fatigue problems, highlighting the value of symptom checklists in noninflammatory disease assessment.
Over 70% of rheumatoid arthritis...
10/31/2025
Rheumatology & Arthritis
Conference Coverage
Specialty Pharmacy Partnership Boosts Shingles Vaccine Uptake in Younger Rheumatoid Arthritis Patients
10/31/2025
Riya Gandhi, MA
A targeted workflow intervention involving pharmacists and coordinated care increased recombinant zoster vaccine uptake from 10% to over 15% among RA patients under 50—surpassing institutional goals and highlighting scalable strategies to...
A targeted workflow intervention involving pharmacists and coordinated care increased recombinant zoster vaccine uptake from 10% to over 15% among RA patients under 50—surpassing institutional goals and highlighting scalable strategies to...
A targeted workflow intervention...
10/31/2025
Rheumatology & Arthritis
Conference Coverage
ERIN Registry Offers First Real-World Look at Rheumatic irAEs from Checkpoint Inhibitors
10/31/2025
Riya Gandhi, MA
Early data from the ERIN registry reveal diverse rheumatic immune-related adverse events (rh-irAEs), with RA-like polyarthritis and age-specific SpA phenotypes dominating presentations—highlighting the need for tailored management approaches.
Early data from the ERIN registry reveal diverse rheumatic immune-related adverse events (rh-irAEs), with RA-like polyarthritis and age-specific SpA phenotypes dominating presentations—highlighting the need for tailored management approaches.
Early data from the ERIN...
10/31/2025
Rheumatology & Arthritis
Conference Coverage
Rheumatoid Arthritis Burden Varies Widely Across U.S. States
10/29/2025
Riya Gandhi, MA
A new analysis of Global Burden of Disease (GBD) 2021 data highlights major state-by-state differences in rheumatoid arthritis burden, with older adults, women, and high-smoking states bearing the greatest health impact.
A new analysis of Global Burden of Disease (GBD) 2021 data highlights major state-by-state differences in rheumatoid arthritis burden, with older adults, women, and high-smoking states bearing the greatest health impact.
A new analysis of Global Burden...
10/29/2025
Rheumatology & Arthritis
Conference Coverage
CME Participation Linked to More Use of JAK Inhibitors in RA
10/29/2025
Jessica Garlewicz
Clinicians who participated in continuing medical education were more likely to switch to a Janus kinase inhibitor to treat their patients with rheumatoid arthritis after lack of response to anti-TNFs.
Clinicians who participated in continuing medical education were more likely to switch to a Janus kinase inhibitor to treat their patients with rheumatoid arthritis after lack of response to anti-TNFs.
Clinicians who participated in...
10/29/2025
Rheumatology & Arthritis
Conference Coverage
Genetic and Environmental Factors Together Improve Prediction of Rheumatoid Arthritis Risk
10/29/2025
Riya Gandhi, MA
A nationwide case-control study using NIH’s All of Us data reveals that integrating genetic risk with air pollution exposure—especially lead and PM2.5—substantially improves prediction of incident rheumatoid arthritis.
A nationwide case-control study using NIH’s All of Us data reveals that integrating genetic risk with air pollution exposure—especially lead and PM2.5—substantially improves prediction of incident rheumatoid arthritis.
A nationwide case-control study...
10/29/2025
Rheumatology & Arthritis
Conference Coverage
Personalized Rehab Boosts Strength, Mobility, and Fitness in Axial Spondyloarthritis
10/28/2025
Riya Gandhi, MA
An 8-week individualized training program led to significant improvements in trunk function and aerobic capacity in patients with axSpA, offering rheumatologists new data to support exercise-based interventions.
An 8-week individualized training program led to significant improvements in trunk function and aerobic capacity in patients with axSpA, offering rheumatologists new data to support exercise-based interventions.
An 8-week individualized...
10/28/2025
Rheumatology & Arthritis
Conference Coverage
IL-17A Inhibitor QX002N Improves Symptoms and Inflammation in r-axSpA by Week 16
10/28/2025
Riya Gandhi, MA
A phase III randomized trial showed QX002N significantly improved clinical outcomes and MRI-assessed inflammation in patients with radiographic axSpA, with a favorable safety profile.
A phase III randomized trial showed QX002N significantly improved clinical outcomes and MRI-assessed inflammation in patients with radiographic axSpA, with a favorable safety profile.
A phase III randomized trial...
10/28/2025
Rheumatology & Arthritis
Conference Coverage
RA-Associated Lung Disease Significantly Increases Risk of Hospitalization and ICU Admission
10/27/2025
Jessica Garlewicz
Rheumatoid arthritis-associated bronchiectasis was associated with hospitalization risks comparable to rheumatoid arthritis-associated interstitial lung disease, an area the study identified as previously underreported.
Rheumatoid arthritis-associated bronchiectasis was associated with hospitalization risks comparable to rheumatoid arthritis-associated interstitial lung disease, an area the study identified as previously underreported.
Rheumatoid arthritis-associated...
10/27/2025
Rheumatology & Arthritis

Features

News
NSAID Prescriptions for Osteoarthritis Decreasing
01/31/2024
Priyam Vora
The observational study assessed changes in, and factors associated with, nonsteroidal anti-inflammatory drug prescriptions for osteoarthritis.
The observational study assessed changes in, and factors associated with, nonsteroidal anti-inflammatory drug prescriptions for osteoarthritis.
The observational study assessed...
01/31/2024
Rheumatology & Arthritis
News
COVID-19 Vaccination and Gout Flares
01/24/2024
Priyam Vora
A recent study looked into the risk of increased gout flares among patients with infrequent flares after receiving their COVID-19 shots.
A recent study looked into the risk of increased gout flares among patients with infrequent flares after receiving their COVID-19 shots.
A recent study looked into the...
01/24/2024
Rheumatology & Arthritis
News
Statins May Lower Risk of Osteoporosis-Related Fractures
01/16/2024
Priyam Vora
Increasing statin dosage may decrease the incidence of osteoporotic fractures, research found.
Increasing statin dosage may decrease the incidence of osteoporotic fractures, research found.
Increasing statin dosage may...
01/16/2024
Rheumatology & Arthritis
News
FDA Approves Interchangeable Biosimilar for Ustekinumab in PsA
12/12/2023
The biosimilar was also approved to treat moderately to severely active Crohn’s disease and ulcerative colitis, and moderate to severe plaque psoriasis.
The biosimilar was also approved to treat moderately to severely active Crohn’s disease and ulcerative colitis, and moderate to severe plaque psoriasis.
The biosimilar was also approved...
12/12/2023
Rheumatology & Arthritis
Current Research
Pregnancy Risks With Psoriatic Diseases
04/26/2021
Psoriatic diseases may increase risk of maternal complications in pregnant patients.
Psoriatic diseases may increase risk of maternal complications in pregnant patients.
Psoriatic diseases may increase...
04/26/2021
Rheumatology & Arthritis

Interactive

Quiz
Progression from PsO to PsA
04/28/2026
Rebecca Mashaw
Do you know which patients with psoriasis are most at risk of progression to psoriatic arthritis? Take our quick quiz to find out!
Do you know which patients with psoriasis are most at risk of progression to psoriatic arthritis? Take our quick quiz to find out!
Do you know which patients with...
04/28/2026
Rheumatology & Arthritis
Quiz
Treat-to-Target vs Symptom-Based Gout Care: What’s the Difference?
04/01/2026
Riya Gandhi, MA
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Test your understanding of gout...
04/01/2026
Rheumatology & Arthritis
Quiz
Why Flare Frequency Matters in Clinical Trials
04/01/2026
Riya Gandhi, MA
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Explore why gout flare frequency...
04/01/2026
Rheumatology & Arthritis
Quiz
Hyperuricemia vs Gout: Understanding the Clinical Relationship
04/01/2026
Riya Gandhi, MA
Test your knowledge of the relationship between hyperuricemia and clinical gout. This quiz clarifies key distinctions that impact diagnosis, risk assessment, and treatment decisions in rheumatology practice.
Test your knowledge of the relationship between hyperuricemia and clinical gout. This quiz clarifies key distinctions that impact diagnosis, risk assessment, and treatment decisions in rheumatology practice.
Test your knowledge of the...
04/01/2026
Rheumatology & Arthritis
Quiz
Pegloticase + Methotrexate: What Rising Uric Acid Means
04/01/2026
Riya Gandhi, MA
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Assess your understanding of...
04/01/2026
Rheumatology & Arthritis
Quiz
Sex-Based Differences in Response to Advanced Therapies in Axial Spondyloarthritis
08/07/2025
Rebecca Mashaw
Do men or women achieve better outcomes with advanced therapies for axial spondyloarthritis? Find out by taking our quick quiz.
Do men or women achieve better outcomes with advanced therapies for axial spondyloarthritis? Find out by taking our quick quiz.
Do men or women achieve better...
08/07/2025
Rheumatology & Arthritis
Quiz
What Factor Increases Mortality in Rheumatoid Arthritis?
08/07/2025
Rebecca Mashaw
One factor showed a substantial association with mortality among patients with rheumatoid arthritis. Find out what it is with our quiz!
One factor showed a substantial association with mortality among patients with rheumatoid arthritis. Find out what it is with our quiz!
One factor showed a substantial...
08/07/2025
Rheumatology & Arthritis
Quiz
How to Assess Frailty in SLE
07/21/2025
Rebecca Mashaw
07/21/2025
Rheumatology & Arthritis
Quiz
Continuation of Therapy With bDMARDs vs JAKs in RA
07/21/2025
Rebecca Mashaw
07/21/2025
Rheumatology & Arthritis
Poll
Assessing Bone Loss in Patients With axSpA
12/05/2024
Rebecca Mashaw
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play...
12/05/2024
Rheumatology & Arthritis

Popular Articles

News
Work Productivity Among Patients With PsA Treated With DMARDS
06/19/2024

Jessica Garlewicz, Digital Managing Editor

Jessica Garlewicz, Digital Managing E...
The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.
The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.
The systematic review and...
06/19/2024
Rheumatology & Arthritis
News
Disease Burden of Occupations on Patients With PsA
10/18/2024
Jessica Garlewicz
More study is needed to gain understanding of how physical work may influence disease activity among patients with psoriatic arthritis.
More study is needed to gain understanding of how physical work may influence disease activity among patients with psoriatic arthritis.
More study is needed to gain...
10/18/2024
Rheumatology & Arthritis
News
Treat-to-Target Approach in RA Found “Suboptimal”
08/14/2024
Rebecca Mashaw
A systematic review sought to identify barriers to implementing treat-to-target in managing rheumatoid arthritis.
A systematic review sought to identify barriers to implementing treat-to-target in managing rheumatoid arthritis.
A systematic review sought to...
08/14/2024
Rheumatology & Arthritis
News
Regional Differences Found in Phenotypes of Patients With axSpA
09/20/2024
Jolynn Tumolo
Investigators suggest this information can help reduce delays in diagnosis and treatment.
Investigators suggest this information can help reduce delays in diagnosis and treatment.
Investigators suggest this...
09/20/2024
Rheumatology & Arthritis
News
Patients With nr-axSpA and r-axSpA Show Differences in Several Key Criteria
06/24/2024
Rebecca Mashaw
Researchers found distinct variations between patients with nonradiographic and radiographic axial spondyloarthritis in age of disease onset, sex, and other factors.
Researchers found distinct variations between patients with nonradiographic and radiographic axial spondyloarthritis in age of disease onset, sex, and other factors.
Researchers found distinct...
06/24/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use